Showing results (1-10 of 310) with videos related to
Sort By:
Pageof 31
Clinical EEG (Electroencephalography)|October 1, 1984
Electroencephalogram in tardive dyskinesiaM E Wolf, W C Koller, A D MosnaimInternational Journal of Clinical Pharmacology and Therapeutics|June 1, 1994
Improvement of axial dystonia with the administration of clozapineM E Wolf, A D MosnaimJournal of Clinical Psychopharmacology|August 1, 1988
Administration of butaperazine and plasma methionine-enkephalin levels in schizophrenic and affective disorder patients with tardive dyskinesiaA D Mosnaim, M E WolfGeneral Pharmacology|January 1, 1983
Phenylethylamine in neuropsychiatric disordersM E Wolf, A D MosnaimAmerican Journal of Therapeutics|July 29, 1999
Effects of the administration of amphetamine, either alone or in combination with reserpine or cocaine, on regional brain beta-phenylethylamine and dopamine releaseF Karoum, M E Wolf, A D MosnaimComparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology|January 1, 1983
Studies in the mechanism of phenylethylamine uptake by rabbit erythrocytesM Mason, M E Wolf, A D MosnaimPsychological Medicine|August 1, 1983
Cognitive functions in tardive dyskinesiaM E Wolf, J J Ryan, A D MosnaimThe Hillside Journal of Clinical Psychiatry|January 1, 1987
Risk factors for tardive dyskinesia according to primary psychiatric diagnosisM E Wolf, A S DeWolfe, A D MosnaimGeneral Pharmacology|January 1, 1989
Hydroxylation of phenylethylamine by rat liver preparations. Inhibition studiesA D Mosnaim, O H Callaghan, M E WolfResearch Communications in Chemical Pathology and Pharmacology|March 1, 1978
Preliminary studies of the sodium borohydride stabilizable binding of phenylethylamine and tyramine to brain preparationsF Ungar, A D Mosnaim, B Ungar, et al.Pageof 31